Calmare Therapeutics Inc (fka CTTC)

[Spocks Stocks]

I find it interesting

That when a new drug is developed for pain relief, a "significant" reduction is 20% using the VAS score. The study just presented describes success as a 50% reduction.

Despite that, the success rate is better for Scrambler.

So more than 50% with neuropathic pain got more than 50% pain relief under less than ideal conditions.

I can see you are rolling on the floor laughing; laughing for joy for all those neuropathic pain sufferers who have a promising treatment confirmed with this new study.

Keep it up chuckles!